BioSpace News Archive

Boston Biomedical announced it had launched an oncology research alliance with Columbia University, Harvard University and The Wistar Institute.

In March, the FDA issued a Complete Response Letter for Zynquista as a treatment for type 1 diabetes.

Global courier for cell and gene therapy, Biocair, will exhibit at Cell Therapy Manufacturing and Gene Therapy Congress between 3-6 December 2019.

Drug licensed for breast and ovarian cancer can also control the growth of some advanced prostate cancers

Micronic, leader in innovative sample storage and automation solutions, launches the state-of-the-art Micronic Tube Handler HT700.

Researchers at The University of Texas MD Anderson Cancer Center have found that a protein involved in immune response to microbes also can fuel cancer development and suppress immune response to the disease.

Celmatix Inc., the leading precision health company advancing the fields of reproductive medicine and fertility at the intersection of big data and genomics, announced a strategic alliance with Evotec, a global leader in drug discovery and development.

With this appointment, all functions of a fully-integrated, late-stage drug development executive leadership team are now in place.

Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that Dr. Jennifer Simpson, Ph.D., Chief Executive Officer and Ms. Barbra Keck, Chief Financial Officer, will present at the 12th Annual LD Micro Main Event investor conference at 1 p.m. PT (4 p.m. ET) on Tuesday, December 10, 2019.

Aflac survey finds families incur debt, give less, or sacrifice time with family and friends